
The AHA responded to a Centers for Medicare & Medicaid Services request for information regarding whether the agency should include exceptions to the electronic prescribing of controlled substances requirements in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.